Main Menu
Log in
Forgot password


Vision for the CINP Pharmacogenetics Global Networking Community ​

The CINP Global Pharmacogenetics Network envisions a professional network where pharmacogenetics in psychiatry is recognized, understood, and addressed through interdisciplinary collaboration, scientific innovation, and education. We aim to drive progress in research, clinical practice, and policy by defining clinically relevant aspects of pharmacogenetics for psychopharmaca and ensuring that (pre-clinical) knowledge is effectively translated into action.


Key Pillars of the Vision

1. Advancing Education & Knowledge Dissemination

  • Establish a global learning ecosystem that trains and equips professionals across disciplines with cutting-edge knowledge on psychopharmacogenetics.
  • Develop accessible e-learning modules, masterclasses, and certification programs tailored for clinicians, researchers, and policymakers.
  • Promote cross-cultural and context-sensitive education, ensuring that findings are applicable across diverse populations.

    2. Driving Research That Captures the Unseen​

    • Encourage research on underevaluated aspects of Pharmacogenetics, including cross continent research and collaborations.
    • Support novel pharmacogenetics discoveries.
    • Foster collaborative global studies that bridge research gaps between regions with varying resources and healthcare infrastructures.

      3. Fostering Innovation & Interdisciplinary Collaboration​

      • Serve as a hub for interdisciplinary exchange, uniting neuroscience, psychiatry, psychology, pharmacology, digital health, and social sciences.
      • Promote the development of next-generation therapeutic approaches, including digital tools, immersive technologies, and novel psychopharmacological interventions.
      • Encourage the use of real-world data and AI-driven analytics to refine treatment strategies.

      4. Enhancing Visibility & Advocacy for Pharmacogenetics

      • Act as a global advocate for pharmacogenetically informed policies, ensuring it is recognized as a public health priority to implement.
      • Highlight populations and pharmacogenetic subtypes that are often overlooked displacement.
      • Engage with media, public health organizations, and governments to shape an evidence-based narrative and policy network

      Pharmacogenetics GNC Members

      Chair: Professor Dr. Roos van Westrhenen (MD, PhD) - The Netherlands

      Invitations to join the core group were sent out. The confirmed members will appear here shortly. 


      ©2024 CINP

      Privacy Policy